The Fields of Medicine and Science Never Stop Moving Forward – and Neither Should Physicians

Physicians spend four years in medical school and three to five years in residency training. For the rest of your career, you rely on CME as one of the support systems that helps you drive improvements in practice and optimize the care, health, and wellness of patients. Whether you work in clinical care, research, healthcare administration, executive leadership, or other areas of medicine, CME is designed to be relevant to your needs, practice-based, and effective.

Participation in accredited CME helps you meet requirements for maintenance of licensure, maintenance of certification, credentialing, membership in professional societies, and other professional privileges. The NMA is dedicated to meeting your educational needs.

Please contact our CME Director Meghan Johnson at meghanj@nebmed.org with any questions you may have.

CONTROLLED SUBSTANCE CME

Since 2020, all physicians who prescribe controlled substances are required to have 3.0 of opioid prescribing CME completed each licensure renewal year due to LB731 (full bill located here). 3.0 hours of the 50.0 hours are required to be on the subject of opioids – 0.5 hours of the 3.0 hours are to be on the PDMP (Prescription Drug Monitoring Program).

LICENSURE VERIFICATION
On the renewal form, physicians will be asked if they prescribe controlled substances and to attest that the CME requirements have been completed.  Please note the 3.0 hours required are included in the 50.0 total CME needed for licensure renewal. View the NE DHHS Controlled Substance Continuing Competency Requirement document here.

FREE CME RESOURCES
Below are links to the videos and CME assessments to fulfill this requirement. Please note: the trainings provided by NMA are free. If you received information from InforMed/Elite Learning their education can be applied toward these requirements but may not cover the 0.5 hours on the PDMP as required by LB 731.

⇒ PDMP 0.5 hours UPDATED (Released 2022 – Expires 04/2025)
Video    CME Assessment

Naloxone 0.5 hours (Released 2018 – Recertification Expires 12/2024)
Video    CME Assessment

⇒ Pain Management Guidance 1.0 hours (Released 2018 – Recertification Expires 12/2024)
Video    CME Assessment

⇒ Acute Pain 0.5 hours (Released 2018 – Recertification Expires 12/2024)
Video    CME Assessment

⇒ Difficult Conversations 0.5 hours (Released 2018 – Recertification Expires 12/2024)
Video    CME Assessment

⇒ Tapering Opioids/Benzodiazepines 0.5 hours (Released 2018 – Recertification Expires 12/2024)
Video    CME Assessment

Given the emergency declaration, do I still have to complete this CME for my October 1 license renewal? 
Governor Ricketts signed 20-27 which allows licensees to defer renewal which was originally set for October 1, 2020.  Once the declared emergency ends, DHHS Licensure will have 30 days to send out renewal notices to those that deferred in which licensees will then have 90 days from that point to complete the renewal of their license.  ALSO, licensees who renew their licenses will have the opportunity to waive their continuing competency requirements due to circumstances beyond their control.  To do this, licensees will be asked if they completed their required CME during the renewal application process.  If hours were not met licensees can ask for a waiver and then specifically state why they were not able to obtain those hours and also provide how many hours you were able to obtain.

It is not guaranteed that these hours will be waived by DHHS given that the resources to complete the 3.0 CME hours have been available long before the pandemic.

I’m obtaining my initial license, does this requirement apply to me?  
No. If you have or are applying for your initial license, the statue does not apply to you until re-licensure.

I don’t prescribe controlled substances, does this requirement apply to me?  
No. The CME requirement only applies to physicians that prescribe controlled substances.

Is there a local, free resource available to meet the 3.0 CME hours as outlined by LB 731?  
Yes. DHHS in partnership with the NMA developed enduring videos that can be accessed and watched at any time to meets the criteria in statute.  Once you complete each video you can then complete an attestation that then provides you with a certificate of completion.

Can I apply the education provided by Informed toward this requirement?
Yes. Please note that their education may not cover the 0.5 hours on the PDMP as required by LB 731.

Do I need to provide a copy of my CME completion certificate to licensure?  
No. The certificate is for your personal recordkeeping and isn’t provided to DHHS Licensure at renewal.  Licensure may audit to ensure that licensees have completed the proper training so we strongly encourage you to save your CME certificates.

How do I obtain a copy of my completion certificate?  
If you completed the education provided by DHHS located on the NMA website, please contact Meghan Johnson at meghanj@nebmed.org.

Why doesn’t the certificate have my name or the date I completed listed on it? 
It is okay that your certificates do not have your name and date of completion on them. Please note that the certificates are for your personal recordkeeping and will not be submitted to DHHS Licensure.

Why does the certificate have a valid date that spans three years?
The CME education is valid for three years but the state of Nebraska now requires that you obtain 3 CME hours each renewal period which is every two years.

How do I notify DHHS Licensure that I have completed this requirement?  
When you complete your license renewal application you will be asked if you prescribe controlled substances and attest that the CME requirements have been completed.

Whom can I talk to about my license renewal?  
Please reach out to the Dept. of Health & Human Services Licensure Unit on their website http://dhhs.ne.gov/licensure/Pages/License-Renewals.aspx, via email DHHS.LicensureUnit@nebraska.gov, or by phone 402-471-2115.

MEDICATION ACCESS & TRAINING EXPANSION (MATE) ACT

The MATE Act standardizes substance use disorder training to ensure that all prescribers of addictive medications possess baseline knowledge in evidence-based addiction prevention and treatments. This ensures that all DEA-controlled medication prescribers have a baseline knowledge of how to prevent addiction and how to identify, treat, and manage patients who have substance use disorders.

Specifically, the MATE Act requires all prescribers of federally controlled substances to complete eight (8) hours of training on treating and managing patients with opioid use disorder (OUD) and substance use disorder (SUD). This requirement begins on the date of your next scheduled DEA registration submission – regardless of whether it is an initial registration or a renewal registration – on or after June 27, 2023.

The NMA’s continuing education entity, NMET, is accredited to provide the training that will meet this new requirement. Recordings of the virtual trainings will be made available on the website following the sessions and can be accessed at any time to receive CME.

Training is being provided in partnership with the Nebraska Department of Health & Human Services

This project is funded in part from the State Opioid Response Grant #H79TI085774 from the Substance Abuse and Mental Health Services Administration Center for Substance Abuse Treatment subgranted through the Nebraska Department of Health and Services, Division of Behavioral Health.

May 12, 2023
8:00-10:00 am CST
Virtual
Intersection of Pain and Substance Use Disorders & Mental Health
2.0 AMA PRA Category 1 Credit(s)TM
Evaluation to claim CME
View Recording
May 19, 2023
8:00-10:00 am CST
Virtual
Stigma and the Neurobiological Components of Addiction (1st hour)
Screening Patients for Substance Use Disorders (2nd hour)
2.0 AMA PRA Category 1 Credit(s)TM
Evaluation to claim CME
View Recording
May 26, 2023
8:00-10:00 am CST
Virtual
Strategies to Address Patients with Co-Morbid Conditions of Pain, Mental Illness, and Substance Use Disorders
2.0 AMA PRA Category 1 Credit(s)™
Evaluation to claim CME
View Recording
June 2, 2023
8:00-10:00 am CST
Virtual
Safe Prescribing and PDMP (1st hour)
Physician Health (2nd hour)
2.0 AMA PRA Category 1 Credit(s)™
Evaluation to claim CME
View Recording
August 17, 2023
1:00-5:00 pm CST
In-person, Lincoln, NE
Common Challenges in Medical Practices: Treating Patients with Substance Use Disorders, Pain, Anxiety, and other Related Conditions
4.0 AMA PRA Category 1 Credit(s)™
Recording available
upon request. Please
email Will Schmeeckle
at wills@nebmed.org
The NMA’s continuing education entity, NMET, is accredited to provide the training that will meet the MATE Act requirements. PLEASE NOTE: The trainings provided by NMA are free. Any information received from InforMed/Elite Learning is solicitation and not related to this NMA education.

Policies and standards of the Nebraska Medical Education Trust require that speakers and planners for continuing medical education activities disclose any relevant financial relationships they may have with commercial interests whose products, devices or services may be discussed in the content of a CME activity. The speaker and planning committee have no relevant financial relationships to disclose.

The Nebraska Medical Education Trust designates each live activity for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The Nebraska Medical Education Trust is accredited by the Nebraska Medical Association to provide continuing medical education for physicians.

Removal of DATA Waiver (X-Waiver) Requirement
Section 1262 of the Consolidated Appropriations Act, 2023 (also known as Omnibus bill), removes the federal requirement for practitioners to submit a Notice of Intent (have a waiver) to prescribe medications, like buprenorphine, for the treatment of opioid use disorder (OUD). With this provision, and effective immediately, SAMHSA will no longer be accepting NOIs (waiver applications).

All practitioners who have a current DEA registration that includes Schedule III authority, may now prescribe buprenorphine for Opioid Use Disorder in their practice if permitted by applicable state law and SAMHSA encourages them to do so. SAMHSA and DEA are actively working on implementation of a separate provision of the Omnibus related to training requirements for DEA registration that becomes effective in June 2023. Please continue to check this webpage for further updates and guidance. Additional information can be found at https://www.samhsa.gov/medications-substance-use-disorders/removal-data-waiver-requirement.

What does this mean for providers?
This means that the special waiver (e.g., a DATA-Waiver) is no longer required to treat patients with opioid use disorder (OUD). Additionally, the DATA-Waiver registration number is no longer required on opioid use disorder prescriptions. Opioid use disorder prescriptions, like all prescriptions, now only require a standard DEA registration number.

  • Those prescribers currently registered with the DEA as a DATA-Waived prescriber should have received, or will be receiving, an updated DEA registration certificate to reflect the elimination of the DATA-Waiver registration number. No action is necessary on the registrant’s part.
  • It should be noted that state laws applicable to this issue may still be in effect. Registrants should take note of their state’s requirements because they may differ from federal law.

SAMHSA Website

Questions for SAMHSA? Contact infobuprenorphine@samhsa.hhs.gov

Please see the letter sent to DEA registered practitioners here which outlines the requirements for training for Medication Assisted Treatment as part of the MATE Act, which was part of the Omnibus Bill at the end of December 2022. DEA was given 90 days to let practitioners know how to meet the MATE Act’s training requirement which is tied to their initial or renewal DEA registration beginning on June 27, 2023. This letter provides the information to the practitioners as to how they can meet those training requirements.

DEA – Diversion Control Division Website
Apply for or Renew Your Registration

Questions for the DEA? Contact ODLP@dea.gov

Project ECHO on Substance Use Disorders and Pain

Project ECHO (Extension for Community Healthcare Outcomes) is an opportunity for prescribers across the state to get specialist knowledge, clinical advice, and recommendations from prescribers with expertise in treating patients with pain and substance use disorders in a virtual learning network. ECHO sessions are targeted to all prescribers interested in learning more about the treatment of patients with pain and substance use disorders. Each ECHO session includes a presentation from one of our experts followed by an opportunity for the audience to present patient cases to our entire panel of experts.

Each one-hour Project ECHO session counts towards the eight hours of required training on opioid and substance use disorders for your DEA license.

For questions or more information, contact Will Schmeeckle, Project Coordinator at NMA at wills@nebmed.org.

Our current ECHO series is focused on:
Practical Components of Treating Patients with Substance Use Disorders in Primary Care

January 12, 2024
7:30-8:30 am CT
Virtual
Practical Office-Based Treatment for Patients with Opioid Use Disorder
Janet Bernard, MD
Ed Kaiser, APRN
January 26, 2024
7:30-8:30 am CT
Virtual
Non-Pharmacological Treatment for Patients with Substance Use Disorders
Stephanie Bennington, DO
Ed Kaiser, APRN
Gayle Keller, APRN
February 9, 2024
7:30-8:30 am CT
Virtual
Deep Dive into Drug Screens
Stephanie Bennington, DO
February 23, 2024
7:30-8:30 am CT
Virtual
Marijuana and Analogues
Todd Stull, MD

Each activity is designated for 1.0 AMA PRA Category 1 Credit(s)TM. You will receive a link to complete the CME evaluation after each session in order to claim CME credit.

Policies and standards of the Nebraska Medical Education Trust require that speakers and planners for continuing medical education activities disclose any relevant financial relationships they may have with commercial interests whose products, devices or services may be discussed in the content of a CME activity. The speaker and planning committee have no relevant financial relationships to disclose. The Nebraska Medical Education Trust designates each live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. The Nebraska Medical Education Trust is accredited by the Nebraska Medical Association to provide continuing medical education for physicians.

Our current ECHO series is focused on:
Practical Components of Treating Patients with Substance Use Disorders in Primary Care

Name Specialty Location
Stephanie Bennington, DO Addiction Psychiatrist Omaha, NE
Janet Bernard, MD Family Physician North Platte, NE
Nathan ‘Ed’ Kaiser, APRN Family Nurse Practitioner Omaha, NE
Gayle Keller, APRN Psychiatric Nurse Practitioner Falls City, NE
John Massey, MD Pain Medicine Specialist Lincoln, NE
Todd Stull, MD Addiction Psychiatrist Lincoln, NE

Training is Being Provided in Partnership with the Nebraska Department of Health & Human Services

This project is funded in full from the State Opioid Response Grant #H79TI085774 from the Substance Abuse and Mental Health Services Administration Center for Substance Abuse Treatment subgranted through the Nebraska Department of Health and Services, Division of Behavioral Health.